Do Parkinson's disease and dementia with Lewy bodies differ by route of environmental precipitant?

Movement Disorders

Volumn 23, Issue 11, 2008, Pages 1617-

  Kurlan, Roger ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEAVY METAL; HERBICIDE; PESTICIDE;

AUTONOMIC NERVOUS SYSTEM; BRAIN DEGENERATION; DEMENTIA; DIFFUSE LEWY BODY DISEASE; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; GENETIC SUSCEPTIBILITY; HEREDITY; HUMAN; LETTER; NEUROPATHOLOGY; OCCUPATIONAL EXPOSURE; OLFACTORY NERVOUS SYSTEM; PARKINSON DISEASE; PATHOGENESIS; PRION; PRIORITY JOURNAL; SYNAPTIC TRANSMISSION; VIRUS TRANSMISSION; ENVIRONMENT;

ENVIRONMENT; HUMANS; LEWY BODY DISEASE; PARKINSON DISEASE;

EID: 53149150972     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.22123     Document Type: Letter

References (13)

1. Braak H, Del Tredici K, Rijb U, de Vos RAI, Jansen Steur ENH, Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003;24:197-211.
2. Del Tredici K, Rub U, de Vos RAI, Bohl JRE, Braak H. Where does Parkinson disease pathology begin in the brain? J Neuropathol Exp Neurol 2002;61:413-426.
3. Wakabayashi K, Takahashi H, Ohama E, Takeda S, Ikuta F. Lewy bodies in the visceral autonomic nervous system in Parkinson's disease. In: Ikuta F, editor. Neuropathology in brain research. Amsterdam, London, Tokyo: Excerpta Medica; 1991. p 133-141.
4. Braak H, De Vos RAI, Bohl JR, Del Tredici K. Gastric alphasynuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology. Neurosci Lett 2006;396:67-72.
5. Minguez-Castellanos A, Charorro CE, Escamilla-Sevilla F, et al. Do α-synuclein aggregates in autonomic plexuses predate Lewy body disorders? A cohort study. Neurology 2007;68:2012-2018.
6. Braak H, Sastre M, Bohl JRE, de Vos RAI, Del Tredici K. Parkinson's disease: lesions in dorsal hom layer 1, involvement of parasympathetic and sympathetic pre- and postganglionic neurons. Acta Neuropathol (Ber) 2007;113:421-429.
7. Oberdörster G, Sharp Z, Atudorei V, et al. Translocation of inhaled ultrafine particles to the brain. Inhal Toxicol 2004; 16:437-445.
8. Ratner MH, Feldman RG. Environmental toxins and Parkinson's disease. In: Ebadi M, Pfeiffer RF, editors. Parkinson's disease. Boca Raton, FL: CRC Press; 2005. p 51-62.
9. Strickland D. Rural environment and Parkinson's disease. In: Ebadi M, Pfeiffer RF, editors. Parkinson's disease. Boca Raton, FL: CRC Press; 2005. p 63-71.
10. Braak H, Bohl JR, Müller CM, Rüb U, de Vos RAI, Del Tredici K. Stanley Fahn Lecture 2005: The staging procedure for the inclusion body pathology associated with sporadic Parkinson's disease reconsidered. Mov Disord 2006;21:2042-2051.
11. Klein C, Schlossmacher MG. Parkinson's disease, 10 years after its genetic revolution: multiple clues to a complex disorder. Neurology 2007;69:2093-2104.
12. McKeith IG, Galasko D, Kosaka K. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the Consortium on DLB International Workshop. Neurology 1996;47:1113-1124.
13. Richard IH, Papka M, Rubio A, et al. Parkinson's disease and dementia with Lewy bodies: one disease or two? Mov Disord 2002;17:1161-1165.